These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

854 related items for PubMed ID: 12420837

  • 1. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
    von Kaisenberg CS, Gasiorek-Wiens A, Bielicki M, Bahlmann F, Meyberg H, Kossakiewicz A, Pruggmayer M, Kamin G, Fritzer E, Harris C, Arnold N, German Speaking Down Syndrome Screening Group.
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
    [Abstract] [Full Text] [Related]

  • 2. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH.
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [Abstract] [Full Text] [Related]

  • 3. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [Abstract] [Full Text] [Related]

  • 4. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH.
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [Abstract] [Full Text] [Related]

  • 5. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
    Borenstein M, Persico N, Kagan KO, Gazzoni A, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
    [Abstract] [Full Text] [Related]

  • 6. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
    Soergel P, Pruggmayer M, Schwerdtfeger R, Muhlhaus K, Scharf A.
    Fetal Diagn Ther; 2006 Jul; 21(3):264-8. PubMed ID: 16601335
    [Abstract] [Full Text] [Related]

  • 7. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
    [Abstract] [Full Text] [Related]

  • 8. Prospective validation of first-trimester combined screening for trisomy 21.
    Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
    [Abstract] [Full Text] [Related]

  • 9. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
    Karadzov-Orlić N, Egić A, Filimonović D, Marinković M, Damnjanović-Pazin B, Milovanović Z, Joksić I, Branković S, Lukić R, Mandić V, Cerović N, Mojović D, Plamenac S, Stanković M, Maglić D, Mikovć Z.
    Srp Arh Celok Lek; 2012 Jul; 140(9-10):606-11. PubMed ID: 23289277
    [Abstract] [Full Text] [Related]

  • 10. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.
    Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH.
    Am J Obstet Gynecol; 2005 Jun; 192(6):1761-7. PubMed ID: 15970804
    [Abstract] [Full Text] [Related]

  • 11. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
    Gasiorek-Wiens A, Tercanli S, Kozlowski P, Kossakiewicz A, Minderer S, Meyberg H, Kamin G, Germer U, Bielicki M, Hackelöer BJ, Sarlay D, Kuhn P, Klapp J, Bahlmann F, Pruggmayer M, Schneider KT, Seefried W, Fritzer E, von Kaisenberg CS, German-Speaking Down Syndrome Screening Group.
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
    [Abstract] [Full Text] [Related]

  • 12. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
    Bindra R, Heath V, Liao A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
    [Abstract] [Full Text] [Related]

  • 13. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH.
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [Abstract] [Full Text] [Related]

  • 14. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO, Hoopmann M, Abele H, Alkier R, Lüthgens K.
    Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005
    [Abstract] [Full Text] [Related]

  • 15. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21.
    Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2009 Jun; 33(6):657-64. PubMed ID: 19408250
    [Abstract] [Full Text] [Related]

  • 16. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O.
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [Abstract] [Full Text] [Related]

  • 17. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS, Huang YY, Hwa KY, Cheng CC, Lee FK.
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [Abstract] [Full Text] [Related]

  • 18. One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
    Nicolaides KH, Bindra R, Heath V, Cicero S.
    J Matern Fetal Neonatal Med; 2002 Jul; 12(1):9-18. PubMed ID: 12422904
    [Abstract] [Full Text] [Related]

  • 19. [Cross-validation of the first trimester screening algorithm of the FMF London on 38,700 pregnancies in Germany].
    Lüthgens K, Abele H, Alkier R, Hoopmann M, Kagan KO.
    Ultraschall Med; 2011 Aug; 32(4):367-72. PubMed ID: 21667432
    [Abstract] [Full Text] [Related]

  • 20. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K, Nicolaides KH.
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.